Over 68 weeks, with a starting dose of 2 mg escalated every 4 weeks: 9 mg dose: 26.4% average body weight reduction (29.1 kg / 64.2 lbs) 12 mg dose: 28.7% average body weight reduction (32.3 kg / 71.2 lbs) Placebo: 2.1% average body weight reduction The milestone achievements tell an even more compelling story

Disclosure of interest: Carmen Garca-Cabo, Lorena Benavente Fernndez, Mara Castan Apilanez, Montserrat Gonzlez Delgado, Davinia Larrosa Campo, Elena Lpez-Cancio, Mara Rico Santos, Sergio Calleja Puerta.: nothing to disclose E-Posters - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.01 - DIAGNOSIS/INVESTIGATION OF STROKE ETIOLOGY P2383 - ESOC25-1567 REDUCING ACUTE ADVANCED IMAGING BURDEN IN ACUTE NEUROLOGICAL PRESENTATIONS: THE ESSENTIAL ROLE OF TELESTROKE NEUROLOGISTS Shayandokht Taleb 1,2 , Navdeep Sangha 1 , Zahra Ajani 1 , Denise Gaffney 1 , Howard Rho 1 , Jeffrey Saver 2 1 Kaiser Permanente Los Angeles Medical Center, Los Angeles, United States, 2 University of California, Los Angeles, Los Angeles, United States Background and Aims: Stroke mimics account for 5-60% of stroke codes
Two moAbs, G12 and A1, were raised by the authors against the main immunogenic epitope of the -gliadin 33-mer
And so I dont know
Is MOTS-c used in dietary supplements
Do you agree that it sounds fantastic